Hepcinat® - contains Sofosbuvir 400mg, the newest drug developed by the Indian company Natco Pharma with the help of high-tech equipment, with all the necessary standards and requirements. The drug is used to treat chronic hepatitis C. Treatment with sofosbuvir is used in a complex with other antivirals during a 'without interferon therapy' in virtually all leading clinics around the world, since this drug, which has undergone a lot of clinical and laboratory studies, showed good results. The effectiveness of the new drug for different genotypes of the virus is 92-96%.